Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
5
×
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
praluent
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
life sciences
regeneron pharmaceuticals
fda
rejection
sanofi
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
amgen
arches
What
bio
healthcare
roundup
american
based
best
cholesterol
continue
crash
debate
industry
kind
nash
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
abbvie’s
america
barbecuing
biogen
camping
cardiologist
center
check
conference
continues
convoluted
day
democrats
dreams
drug
drugs
expensive
faces
financial
Language
unset
Current search:
praluent
×
" indiana blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More